Fosun leads the race to buy Gland Pharma with $1.27 billion bid
MUMBAI: Shanghai Fosun Pharmaceutical (Group) Co, part of Chinese billionaire Guo Guangchang's sprawling business empire, has emerged the highest bidder for KKR-backed Gland Pharma at a little over a billion dollars as it looks to increase its research and manufacturing capacity…